All posts by: Michael Zand

About Michael Zand

Immunotherapy Treatments for Cancer Gain Momentum – Wall Street Journal

Continue reading

2017-10-12 NEWS

Wall Street Journal

Immunotherapy Treatments for Cancer Gain Momentum
Wall Street Journal
The science of using immunotherapy to treat cancer is advancing rapidly, marked by the National Cancer Institute’s recent disclosure that a metastatic breast-cancer patient is now cancer-free, regulators’ expected approval of a major lymphoma treatment
NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new cancer …National Institutes of Health (press release)
US NIH teams up with 11 companies to speed cancer immunotherapy researchXinhua
To accelerate new cancer treatments, NIH will team up with pharma on immunotherapy researchSTAT
EurekAlert (press release) –The Hill –Reuters
all 11 news articles »
Continue reading

2017-10-12 NEWS

Newsweek

Gene Therapy: How a New Cure for Blindness Reverses Retinal Dystrophy
Newsweek
A Food and Drug Administration committee is considering whether a gene therapy touted as a breakthrough for people with a particular genetic form of blindness is effective. An FDA approval for the treatment, Luxturna, would be a landmark event for gene …
FDA Vote Sets Stage for Gene Therapy’s FutureMIT Technology Review
The Time Has Come: 4 Gene Therapy Stocks to Buy, 1 to AvoidBarron’s
Live updates: FDA advisory panel reviews Spark’s gene therapySTAT
Philly.com –WebMD –ABC News
all 19 news articles »